Related Experiment Video
Updated: Aug 15, 2026

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
Published on: January 13, 2026
Catheter thrombosis
13805 Green Trails South, Austin, Texas 78731, USA. gerald@beathard.com
Insights
Catheter malfunction, often caused by fibrin sheath thrombus, requires prompt treatment to ensure adequate dialysis. While urokinase is unavailable, recombinant tissue plasminogen activator (tPA) shows promise, but catheter exchange remains the current best solution.
Area of Science:
- Nephrology
- Vascular Access Management
Background:
- Catheter malfunction, particularly due to poor flow, is a frequent complication in dialysis.
- Early malfunctions are typically technical, while late issues often stem from thrombus formation, most commonly the fibrin sheath thrombus.
Purpose of the Study:
- To review the causes and management of catheter malfunction in dialysis.
- To explore potential therapeutic alternatives following the unavailability of urokinase.
Main Methods:
- Literature review on catheter malfunction causes and treatments.
- Discussion of thrombus types and formation mechanisms.
- Evaluation of recombinant tissue plasminogen activator (tPA) as a potential alternative.
Main Results:
- Fibrin sheath thrombus is the most prevalent cause of late catheter malfunction.
- Urokinase, a previous treatment, is no longer available.
- Recombinant tissue plasminogen activator (tPA) is a potential but not optimally packaged alternative.
Conclusions:
- Prompt treatment of catheter malfunction is crucial to prevent inadequate dialysis.
- Catheter exchange is currently the most reliable management strategy for catheter malfunction.
- Further development of tPA packaging is needed for optimal use in this context.
Abstract:
Catheter malfunction due to poor flow is a common problem. When it occurs early, the cause is generally technical. Late occurrences are most often related to thrombus formation. Several types of thrombus may be seen, differing by location and supposed mechanism of formation. The most common offender, however, is the fibrin sheath thrombus. Prevention of catheter malfunction is an endeavor that continues to beg many questions. Catheter malfunction should be treated early to avoid inadequate dialysis. In the past, urokinase was a highly valuable aid to the nephrologist in managing this problem. Since this agent became unavailable a suitable alternative has not emerged. Recombinant tissue plasminogen activator (tPA) seems to be the most likely candidate for this role; however, it is not currently available in a packaging form that is optimal for this purpose. Currently, catheter exchange appears to be the best available alternative for this problem, which cannot yet be resolved by simpler means.
More Related Videos
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization III: Left Heart Catheterization
Cardiac Catheterization IV: Nursing Management
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care

